MedTrace Logo

Feasibility Study of the µCor Heart Failure and Arrhythmia Management System (PATCH)

NCT04512703 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 51

Last updated 2021-06-03

Study results available
· View outcomes & findings →

Summary

Prospective, non-interventional, feasibility study. 8 months, from start of screening to finishing the study. Multi-center study, with a maximum of 8 centers in Europe. Health adult volunteers (21 years or older) and adult patients with a clinical indication for ambulatory outpatient cardiac monitoring.

To observe the feasibility of remotely monitoring patients with the novel µCor Heart Failure and Arrhythmia Management System (µCor system ) that non-invasively captures thoracic fluid content, electrocardiogram, heart rate, respiratory rate, activity, and body posture. tory outpatient cardiac monitoring.

Conditions

  • Heart Arrhythmia

Interventions

DEVICE

µCor

Sensor Monitor for arrhythmia and other bio-metric markers

Sponsors & Collaborators

  • Zoll Medical Corporation

    lead INDUSTRY

Principal Investigators

  • Mike Osz · Zoll Medical Corporation

Eligibility

Min Age
21 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2018-10-25
Primary Completion
2020-08-02
Completion
2020-08-02
FDA Device
Yes

Countries

  • Germany

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04512703 on ClinicalTrials.gov